Showing results (1571-1580 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|January 18, 2024
The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health ConditionsCate Bailey, Kim Dalziel, Renee Jones, et al.Pharmacoeconomics|July 14, 2012
A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthmaWendy J Ungar, Katherine Boydell, Sharon Dell, et al.Pharmacoeconomics|May 7, 1998
The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) StudyP K Schädlich, J G BrechtPharmacoeconomics|November 7, 2000
Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET ProjectJ E Zwart-van Rijkom, H G Leufkens, J J Busschbach, et al.Pharmacoeconomics|April 13, 2002
Enoxaparin: a pharmacoeconomic review of its use in the prevention and treatment of venous thromboembolism and in acute coronary syndromesDavid BergqvistPharmacoeconomics|December 21, 2004
The effect of cost construction based on either DRG or ICD-9 codes or risk group stratification on the resulting cost-effectiveness ratiosElinor C G Chumney, Andrea K Biddle, Kit N Simpson, et al.Pharmacoeconomics|May 20, 2003
The economics of screening and treatment in type 2 diabetes mellitusMaria Raikou, Alistair McGuirePharmacoeconomics|November 5, 2004
Etanercept: a pharmacoeconomic review of its use in rheumatoid arthritisKatherine A Lyseng-Williamson, Greg L PloskerPharmacoeconomics|February 1, 2006
Bayesian methods for evidence synthesis in cost-effectiveness analysisA E Ades, Mark Sculpher, Alex Sutton, et al.Pharmacoeconomics|May 19, 2006
Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trialShelby D Reed, Jasmina I Radeva, Davey B Daniel, et al.Pageof 336